These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 19996427

  • 1. Clinical, parasitologic, and immunologic evolution in dogs experimentally infected with sand fly-derived Leishmania chagasi promastigotes.
    Travi BL, Osorio EY, Saldarriaga OA, Cadena H, Tabares CJ, Peniche A, Lee S, Melby PC.
    Am J Trop Med Hyg; 2009 Dec; 81(6):994-1003. PubMed ID: 19996427
    [Abstract] [Full Text] [Related]

  • 2. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G.
    Vaccine; 2007 May 22; 25(21):4223-34. PubMed ID: 17395339
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D, Baneth G, Shor S, Okano F, Jaffe CL.
    Int J Parasitol; 2005 Jan 22; 35(1):63-73. PubMed ID: 15619517
    [Abstract] [Full Text] [Related]

  • 4. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE.
    Parassitologia; 2004 Jun 22; 46(1-2):227-9. PubMed ID: 15305723
    [Abstract] [Full Text] [Related]

  • 5. Splenic immune responses during canine visceral leishmaniasis.
    Strauss-Ayali D, Baneth G, Jaffe CL.
    Vet Res; 2007 Jun 22; 38(4):547-64. PubMed ID: 17540157
    [Abstract] [Full Text] [Related]

  • 6. Canine visceral leishmaniasis: dog infectivity to sand flies from non-endemic areas.
    Travi BL, Ferro C, Cadena H, Montoya-Lerma J, Adler GH.
    Res Vet Sci; 2002 Feb 22; 72(1):83-6. PubMed ID: 12002643
    [Abstract] [Full Text] [Related]

  • 7. Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs.
    Poot J, Rogers ME, Bates PA, Vermeulen A.
    Vet Parasitol; 2005 Jun 10; 130(1-2):41-53. PubMed ID: 15893068
    [Abstract] [Full Text] [Related]

  • 8. Peripheral blood mononuclear cell supernatants from asymptomatic dogs immunized and experimentally challenged with Leishmania chagasi can stimulate canine macrophages to reduce infection in vitro.
    Rodrigues CA, Batista LF, Teixeira MC, Pereira AM, Santos PO, de Sá Oliveira GG, de Freitas LA, Veras PS.
    Vet Parasitol; 2007 Feb 28; 143(3-4):197-205. PubMed ID: 17045743
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal analysis of cytokine gene expression and parasite load in PBMC in Leishmania infantum experimentally infected dogs.
    Sanchez-Robert E, Altet L, Alberola J, Rodriguez-Cortés A, Ojeda A, López-Fuertes L, Timon M, Sanchez A, Francino O.
    Vet Immunol Immunopathol; 2008 Sep 15; 125(1-2):168-75. PubMed ID: 18514330
    [Abstract] [Full Text] [Related]

  • 10. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL, Holzmuller P, Cavaleyra M, Gonçalves RB, Hottin G, Papierok G.
    Vaccine; 2005 Apr 22; 23(22):2825-40. PubMed ID: 15780731
    [Abstract] [Full Text] [Related]

  • 11. Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs.
    de Andrade RA, Reis AB, Gontijo CM, Braga LB, Rocha RD, Araújo MS, Vianna LR, Martins-Filho OA.
    Vet Immunol Immunopathol; 2007 Mar 15; 116(1-2):85-97. PubMed ID: 17287029
    [Abstract] [Full Text] [Related]

  • 12. A long term experimental study of canine visceral leishmaniasis.
    Rodríguez-Cortés A, Ojeda A, López-Fuertes L, Timón M, Altet L, Solano-Gallego L, Sánchez-Robert E, Francino O, Alberola J.
    Int J Parasitol; 2007 May 15; 37(6):683-93. PubMed ID: 17239885
    [Abstract] [Full Text] [Related]

  • 13. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.
    Daneshvar H, Molaei MM, Kamiabi H, Burchmore R, Hagan P, Stephen Phillips R.
    Parasite Immunol; 2010 May 15; 32(11-12):722-30. PubMed ID: 21039612
    [Abstract] [Full Text] [Related]

  • 14. Cytokine gene expression in the tissues of dogs infected by Leishmania infantum.
    Barbosa MA, Alexandre-Pires G, Soares-Clemente M, Marques C, Rodrigues OR, De Brito TV, Da Fonseca IP, Alves LC, Santos-Gomes GM.
    J Comp Pathol; 2011 Nov 15; 145(4):336-44. PubMed ID: 21511273
    [Abstract] [Full Text] [Related]

  • 15. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis.
    Chamizo C, Moreno J, Alvar J.
    Vet Immunol Immunopathol; 2005 Jan 10; 103(1-2):67-75. PubMed ID: 15626462
    [Abstract] [Full Text] [Related]

  • 16. Cytokine expression in dogs with natural Leishmania infantum infection.
    Panaro MA, Brandonisio O, Cianciulli A, Cavallo P, Lacasella V, Paradies P, Testini G, De Caprariis D, Mitolo V, Otranto D.
    Parasitology; 2009 Jul 10; 136(8):823-31. PubMed ID: 19490725
    [Abstract] [Full Text] [Related]

  • 17. Idiotype expression of IgG1 and IgG2 in dogs naturally infected with Leishmania infantum.
    Iniesta L, Gállego M, Portús M.
    Vet Immunol Immunopathol; 2007 Oct 15; 119(3-4):189-97. PubMed ID: 17631971
    [Abstract] [Full Text] [Related]

  • 18. Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum.
    Rosypal AC, Zajac AM, Troy GC, Lindsay DS.
    Vet Parasitol; 2005 Jun 10; 130(1-2):19-27. PubMed ID: 15893066
    [Abstract] [Full Text] [Related]

  • 19. Advances in the pathogenesis of canine leishmaniosis: epidemiologic and diagnostic implications.
    Saridomichelakis MN.
    Vet Dermatol; 2009 Oct 10; 20(5-6):471-89. PubMed ID: 20178485
    [Abstract] [Full Text] [Related]

  • 20. The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine.
    Saraiva EM, de Figueiredo Barbosa A, Santos FN, Borja-Cabrera GP, Nico D, Souza LO, de Oliveira Mendes-Aguiar C, de Souza EP, Fampa P, Parra LE, Menz I, Dias JG, de Oliveira SM, Palatnik-de-Sousa CB.
    Vaccine; 2006 Mar 20; 24(13):2423-31. PubMed ID: 16386824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.